Adjuvant therapy in the treatment of stage II uterine carcinoma

被引：1
|
作者：
Berry, L. K. [1 ]
Harbin, L. M. [1 ]
Buchanan, T. R. [2 ]
Kohler, M. F. [1 ]
Cooper, L. [1 ]
Creasman, W. T. [1 ]
Graybill, W. A. [1 ]
机构：
[1] Med Univ South Carolina, Charleston, SC 29425 USA
[2] Washington Univ, Sch Med St Louis, St Louis, MO USA
来源：
GYNECOLOGIC ONCOLOGY | 2018年 / 149卷 / 03期
关键词：
D O I：
10.1016/j.ygyno.2018.03.019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10
引用
收藏
页码：623 / 624
页数：2
相关论文
共 50 条
  • [21] Optimal adjuvant therapy and outcomes for early-stage uterine serous and clear cell carcinoma
    McEachron, Jennifer
    Zhou, Nancy
    Bennett, Michelle
    Hastings, Victoria
    Kanis, Margaux
    Gorelick, Constantine
    Lee, Yi-Chun
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S221 - S221
  • [22] Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy
    Tate, Keisei
    Yoshida, Hiroshi
    Ishikawa, Mitsuya
    Uehara, Takashi
    Ikeda, Shun-ichi
    Hiraoka, Nobuyoshi
    Kato, Tomoyasu
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2018, 29 (03)
  • [23] Impact of adjuvant therapy on oncologic outcomes in early-stage uterine clear cell carcinoma
    Nobre, S. Pedra
    Ataseven, B.
    Bois, A. D.
    Makker, V.
    Alektiar, K.
    Leitao, M. M., Jr.
    Abu-Rustum, N. R.
    Mueller, J. J.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 325 - 325
  • [24] Adjuvant therapy in women with early stage uterine serous carcinoma: A multi-institutional study
    Kurnit, Katherine C.
    Nobre, Silvana Pedra
    Fellman, Bryan M.
    Iglesias, David A.
    Lindemann, Kristina
    Jhingran, Anuja
    Eriksson, Ane Gerda Z.
    Ataseven, Beyhan
    Glaser, Gretchen E.
    Mueller, Jennifer J.
    Westin, Shannon N.
    Soliman, Pamela T.
    GYNECOLOGIC ONCOLOGY, 2022, 167 (03) : 452 - 457
  • [25] A comparison of adjuvant therapy approaches for patients with early-stage uterine serous carcinoma.
    Kurnit, Katherine
    Nobre, Silvana Pedra
    Fellman, Bryan M.
    Iglesias, David A.
    Lindemann, Kristina
    Eriksson, Ane Gerda Zahl
    Atasevan, Beyhan
    Glaser, Gretchen Elizabeth
    Mueller, Jennifer Jean
    Soliman, Pamela T.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [26] Effect of adjuvant therapy on the prognosis in stage I/II uterine carcinosarcoma: A meta-analysis
    Zhao, Fei
    Tan, Ping
    Wang, Chang
    Ji, Xuechao
    Chen, Aiping
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2021, 47 (07) : 2473 - 2480
  • [27] Adjuvant therapy of uterine clear cell carcinoma: a review
    Xu, Yiqing
    Hanna, Rabbie K.
    Elshaikh, Mohamed A.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2016, 293 (03) : 485 - 492
  • [28] Adjuvant therapy of uterine clear cell carcinoma: a review
    Yiqing Xu
    Rabbie K. Hanna
    Mohamed A. Elshaikh
    Archives of Gynecology and Obstetrics, 2016, 293 : 485 - 492
  • [29] Adjuvant therapy in stage I carcinoma of the breast
    Schwartz, Gordon F.
    Reis-Fihlo, Jorge
    Pusztai, Lajos
    Fentiman, Ian S.
    Holland, Roland
    Bartelink, Harry
    Rutgers, Emiel J. T.
    Solin, Lawrence J.
    Palazzo, Juan
    CANCER, 2012, 118 (08) : 2031 - 2038
  • [30] OBSERVATIONS ON THE USE OF ADJUVANT RADIATION-THERAPY IN PATIENTS WITH STAGE-I AND STAGE-II UTERINE SARCOMA
    HORNBACK, NB
    OMURA, G
    MAJOR, FJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (12): : 2127 - 2130
12345